Name: Peter Papenhausen
Title: National Director of Cytogenetics, Laboratory Corporation of America
NEW YORK (GenomeWeb News) – Two new loci have been linked to elevated risk for a childhood embryonal kidney cancer called Wilms tumor, according to a study appearing online yesterday in Nature Genetics.
Using custom microarrays and bisulfite sequencing, researchers have garnered evidence of extensive shifts and variability in methylation patterns in the genomes of several types of cancers.
Biovista will use its Clinical Outcomes Search Space platform to identify new treatments as part of the EU's "p-medicine" project.
The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.
Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.
In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.
Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.